Currently, there are 57.49M common shares owned by the public and among those 56.89M shares have been available to trade.
The company’s stock has a 5-day price change of 49.41% and 9.80% over the past three months. CNSP shares are trading 16.28% year to date (YTD), with the 12-month market performance down to -99.01% lower. It has a 12-month low price of $0.08 and touched a high of $23.90 over the same period. CNSP has an average intraday trading volume of 16.61 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 36.53%, 30.35%, and -92.03% respectively.
Institutional ownership of Cns Pharmaceuticals Inc (NASDAQ: CNSP) shares accounts for 5.66% of the company’s 57.49M shares outstanding.
It has a market capitalization of $8.05M and a beta (3y monthly) value of 1.06. The earnings-per-share (ttm) stands at -$75.02. Price movements for the stock have been influenced by the stock’s volatility, which stands at 24.54% over the week and 13.07% over the month.
Analysts forecast that Cns Pharmaceuticals Inc (CNSP) will achieve an EPS of 0 for the current quarter, 0 for the next quarter and 0 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0 while analysts give the company a high EPS estimate of 0. EPS should grow at an annualized rate of 92.16% over the next five years, compared to 17.98% over the past 5-year period.
Ladenburg Thalmann coverage for the Cns Pharmaceuticals Inc (CNSP) stock in a research note released on August 24, 2020 offered a Buy rating with a price target of $11.
